** Shares of Recce Pharmaceuticals RCE.AX fall 2.3% to A$0.420, their lowest since February 21, 2024
** Pharmaceutical co posts HY net loss attributable of A$7.7 million ($4.80 million) vs A$7.5 million last year
** 298,576 shares change hands, 2.4x the 30-day average of 126,982 shares
** Stock flat YTD, including moves in day's session
($1 = 1.6054 Australian dollars)
(Reporting by Jasmeen Ara Shaikh in Bengaluru)
((Jasmeenaraislam.shaikh@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。